Devon Conway
Staff Neurologist in the Neurological Institute’s Mellen Center for Multiple Sclerosis Treatment and Research · Cleveland Clinic Foundation
Credentials: · · ·
History
Present
- 2010–2011
- 2005–2006
1997–2001
Research
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
Review · Neurotherapeutics · 2017 · Last of 3 authors · 107 citations
Combination therapy in multiple sclerosis
Review · The Lancet Neurology · 2010 · First of 2 authors · 95 citations
Journal of Multiple Sclerosis · 2017 · First of 3 authors · 88 citations
18 papers
15 papers
14 papers
11 papers
6 papers · 1 as a fellow
6 papers
6 papers
5 papers
Clinical trials
- 2017–2019
Gilenya's Impact on Cognitive Function and Thalamic Volumes
Principal investigator · Completed
The Cleveland Clinic
- 2025–2031
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
- 2024–2029
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
Site PI · Recruiting · Phase 4
University of Colorado, Denver